Steven Vanderschueren
Overview
Explore the profile of Steven Vanderschueren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreel L, Doumen M, Betrains A, De Langhe E, Blockmans D, Vanderschueren S
Semin Arthritis Rheum
. 2025 Mar;
72:152695.
PMID: 40022967
Objective: To validate the polymyalgia rheumatica-activity score (PMR-AS). Methods: Prospective cohort study at the University Hospitals Leuven (Belgium) between July 2022 and December 2023. We created a new alternative PMR-AS...
2.
Moreel L, Betrains A, Boeckxstaens L, Pieters G, Wuyts E, Weynand B, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 40000462
Purpose: To evaluate the diagnostic accuracy of PET/CT, cranial MRI, ultrasound and temporal artery biopsy (TAB) in patients with suspected giant cell arteritis (GCA) in a direct comparison. Methods: Consecutive...
3.
Wright W, Stelmash L, Betrains A, Mulders-Manders C, Rovers C, Vanderschueren S, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae538.
PMID: 39376787
No abstract available.
4.
Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, et al.
Rheumatology (Oxford)
. 2024 Aug;
PMID: 39173669
Objectives: To evaluate differences in presentation and outcome of giant cell arteritis (GCA) patients with and without large vessel vasculitis (LVV) and according to the extent and severity of LVV....
5.
Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, et al.
Semin Arthritis Rheum
. 2024 Jul;
68:152499.
PMID: 38968729
Objectives: To evaluate differences in presentation and outcome of giant cell arteritis (GCA) patients with and without polymyalgia rheumatica (PMR) symptoms. Methods: Consecutive patients diagnosed with GCA between 2000 and...
6.
Wright W, Stelmash L, Betrains A, Mulders-Manders C, Rovers C, Vanderschueren S, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae298.
PMID: 38966848
Background: Fever of unknown origin (FUO) and inflammation of unknown origin (IUO) are syndromes commonly used as medical diagnoses. Since the existing literature has a mixture of diagnostic approaches, developing...
7.
Moreel L, Betrains A, De Langhe E, Vanderschueren S, Blockmans D
Rheumatology (Oxford)
. 2024 May;
63(12):e325-e327.
PMID: 38759111
No abstract available.
8.
Moreel L, Betrains A, De Langhe E, Blockmans D, Vanderschueren S
Eur J Intern Med
. 2024 Apr;
126:134-136.
PMID: 38688812
No abstract available.
9.
Blockmans D, Moreel L, Betrains A, Vanderschueren S, Coudyzer W, Boeckxstaens L, et al.
Front Med (Lausanne)
. 2024 Apr;
11:1384533.
PMID: 38572159
Background: A positive PET scan at diagnosis was associated with a greater yearly increase in ascending and descending aortic diameter and thoracic aortic volume in patients with giant cell arteritis...
10.
Moreel L, Boeckxstaens L, Betrains A, Smans T, Molenberghs G, Van Laere K, et al.
Rheumatology (Oxford)
. 2024 Mar;
63(12):3331-3336.
PMID: 38547403
Objectives: Two recent meta-analyses reported subclinical vasculitis in 22-23% of patients with PMR. We aimed to evaluate the prevalence, characteristics, and outcome of subclinical vasculitis among our PMR patients. Methods:...